Nuvo Pharmaceuticals Inc., a commercial healthcare company, produces and sells pharmaceutical products in the United States, Canada, and Europe. It offers Pennsaid, a topical pain product that is used to treat the signs and symptoms of osteoarthritis of the knee; Pennsaid 2%, a follow-on product to Pennsaid for the treatment of the pain of osteoarthritis of the knee; Heated Lidocaine/Tetracaine (HLT) Patch, a topical patch that provides local analgesia prior to painful needle procedures, such as dialysis, blood draws, and pediatric needles; and Resultz, an over-the-counter product intended to kill head lice and remove their eggs from hair. The company was formerly known as Nuvo Research Inc. and changed its name to Nuvo Pharmaceuticals Inc. in March 2016. Nuvo Pharmaceuticals Inc. was founded in 1983 and is headquartered in Mississauga, Canada.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone905-673-6980
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$15.43 million
Profitability
Miscellaneous
Employees97
Next Earnings Date4/3/2020 (Estimated)
OptionableNot Optionable
Nuvo Pharmaceuticals (OTCMKTS:NRIFF) Frequently Asked Questions
What is Nuvo Pharmaceuticals' stock symbol?
Nuvo Pharmaceuticals trades on the OTCMKTS under the ticker symbol "NRIFF."
How were Nuvo Pharmaceuticals' earnings last quarter?
Nuvo Pharmaceuticals Inc (OTCMKTS:NRIFF) released its quarterly earnings data on Thursday, October, 31st. The company reported $0.01 EPS for the quarter. The business earned $14.26 million during the quarter. Nuvo Pharmaceuticals had a negative net margin of 1.56% and a negative return on equity of 43.73%. View Nuvo Pharmaceuticals' Earnings History.
When is Nuvo Pharmaceuticals' next earnings date?
Has Nuvo Pharmaceuticals been receiving favorable news coverage?
News coverage about NRIFF stock has trended somewhat negative recently, InfoTrie reports. The research firm ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Nuvo Pharmaceuticals earned a coverage optimism score of -1.1 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Nuvo Pharmaceuticals.
Who are some of Nuvo Pharmaceuticals' key competitors?
Some companies that are related to Nuvo Pharmaceuticals include Regulus Therapeutics (RGLS), Guardion Health Sciences (GHSI), Aytu Bioscience (AYTU), IMMURON LTD/S (IMRN), Aileron Therapeutics (ALRN), KITOV PHARMA LT/S (KTOV), Novelion Therapeutics (NVLNF), Dare Bioscience (DARE), Advaxis (ADXS), KemPharm (KMPH), Acerus Pharmaceuticals (ASPCF), Conatus Pharmaceuticals (CNAT), Novelion Therapeutics (NVLN), MYOS (MYOS) and Sophiris Bio (SPHS).
Who are Nuvo Pharmaceuticals' key executives?
Nuvo Pharmaceuticals' management team includes the folowing people:
- Mr. Robert Paul Harris, Exec. Chairman (Age 64)
- Mr. Jesse F. Ledger, Pres & CEO
- Ms. Mary-Jane E. Burkett CPA-CA, HBA, VP & CFO
- Ms. Katina K. Loucaides M.Sc., LL.B, VP, Corp. Sec. & Gen. Counsel
- Mr. Calogero Lunetta MSc, VP of Manufacturing
How do I buy shares of Nuvo Pharmaceuticals?
Shares of NRIFF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Nuvo Pharmaceuticals' stock price today?
One share of NRIFF stock can currently be purchased for approximately $0.34.
How big of a company is Nuvo Pharmaceuticals?
What is Nuvo Pharmaceuticals' official website?
How can I contact Nuvo Pharmaceuticals?
Nuvo Pharmaceuticals' mailing address is 6733 MISSISSAUGA ROAD SUIT 610, MISSISSAUGA A6, L5N 6J5. The company can be reached via phone at 905-673-6980 or via email at [email protected]
MarketBeat Community Rating for Nuvo Pharmaceuticals (OTCMKTS NRIFF)
MarketBeat's community ratings are surveys of what our community members think about Nuvo Pharmaceuticals and other stocks. Vote "Outperform" if you believe NRIFF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NRIFF will underperform the S&P 500 over the long term. You may vote once every thirty days.
